References
- Tuppen HA, Blakely EL, Turnbull DM. Taylor RW: mitochondrial DNA mutations and human disease. Biochim Biophys Acta. 2010;1797:113–128. Epub 2009 Sep 1015. doi: https://doi.org/10.1016/j.bbabio.2009.09.005
- Elson JL. Lightowlers RN: mitochondrial DNA clonality in the dock: can surveillance swing the case? Trends Genet. 2006;22:603–607. Epub 2006 Sep 1018. doi: https://doi.org/10.1016/j.tig.2006.09.004
- Elson JL, Swalwell H, Blakely EL, et al. Turnbull DM: pathogenic mitochondrial tRNA mutations–which mutations are inherited and why? Hum Mutat. 2009;30:E984–E992. doi:https://doi.org/10.1002/humu.21113.
- Bury AG, Pyle A, Elson JL, et al. Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease. Ann Neurol. 2017;82:1016–1021. doi:https://doi.org/10.1002/ana.25099. Epub 22017 Dec 25094.
- Hudson G, Carelli V, Spruijt L, et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet. 2007;81:228–233. doi:https://doi.org/10.1086/519394. Epub 512007 Jun 519394.
- Queen RA, Steyn JS, Lord P, et al. Mitochondrial DNA sequence context in the penetrance of mitochondrial t-RNA mutations: A study across multiple lineages with diagnostic implications. PLoS One. 2017;12:e0187862. eCollection 0182017. doi: https://doi.org/10.1371/journal.pone.0187862
- O'Keefe H, Queen RA, Meldau S, et al. Haplogroup context is less important in the penetrance of mitochondrial DNA complex I mutations compared to mt-tRNA mutations. J Mol Evol. 2018;9:018–9855.
- Gorman GS, Elson JL, Newman J, et al. Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease. Neuromuscul Disord. 2015;25:563–566. Epub 2015 Apr 1023. doi: https://doi.org/10.1016/j.nmd.2015.03.001
- Jones DE, Hollingsworth KG, Jakovljevic DG, et al. Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study. Eur J Clin Invest. 2012;42:186–194. doi:1https://doi.org/10.1111/j.1365-2362.2011.02567.x. Epub 02011 Jul 02512.
- Lane RJ, Barrett MC, Taylor DJ, et al. Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuromuscul Disord. 1998;8:204–209. doi: https://doi.org/10.1016/S0960-8966(98)00021-2
- Brown AE, Jones DE, Walker M, et al. Abnormalities of AMPK activation and glucose uptake in cultured skeletal muscle cells from individuals with chronic fatigue syndrome. PLoS One. 2015;10:e0122982. eCollection 0122015. doi: https://doi.org/10.1371/journal.pone.0122982
- Comhaire F. Treating patients suffering from myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) with sodium dichloroacetate: An open-label, proof-of-principle pilot trial. Med Hypotheses. 2018;114:45–48. Doi: https://doi.org/10.1016/j.mehy.2018.1003.1002. Epub 2018 Mar 1015. doi: https://doi.org/10.1016/j.mehy.2018.03.002
- Galan F, de Lavera I, Cotan D, et al. Mitochondrial Myopathy in Follow-up of a patient With chronic fatigue syndrome. J Investig Med High Impact Case Rep. 2015;3. doi:23247096156079https://doi.org/10.2324/709615601177/2324709615607908. eCollection 2324709615602015 Jul-Sep.
- Schoeman EM, Van Der Westhuizen FH, Erasmus E, et al. Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome. BMC Med Genet. 2017;18:29. doi:https://doi.org/10.1186/s12881-12017-10387-12886 doi: https://doi.org/10.1186/s12881-017-0387-6
- Elson JL, Majamaa K, Howell N, Chinnery PF. Associating mitochondrial DNA variation with complex traits. Am J Hum Genet. 2007;80:378–382. author reply 382-373. doi:3https://doi.org/10.1086/511652.
- Ban M, Elson J, Walton A, et al. Investigation of the role of mitochondrial DNA in multiple sclerosis susceptibility. PLoS One. 2008;3:e2891. doi:28https://doi.org/10.1371/journal.pone.0002891.
- Billing-Ross P, Germain A, Ye K, Keinan A, Gu Z, Hanson MR. Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2016;14:19. Doi:https://doi.org/10.1186/s12967-12016-10771-12966 doi: https://doi.org/10.1186/s12967-016-0771-6
- Salas A, Elson JL. Mitochondrial DNA as a risk factor for false positives in case-control association studies. J Genet Genomics. 2015;42:169–172. doi:1https://doi.org/10.1016/j.jgg.2015.1003.1002. Epub 2015 Mar 1017. doi: https://doi.org/10.1016/j.jgg.2015.03.002
- Venter M, Malan L, van Dyk E, et al. Using MutPred derived mtDNA load scores to evaluate mtDNA variation in hypertension and diabetes in a two-population cohort: The SABPA study. J Genet Genomics. 2017;44:139–149. doi:1https://doi.org/10.1016/j.jgg.2016.1012.1003. Epub 2016 Dec 1026. doi: https://doi.org/10.1016/j.jgg.2016.12.003
- Pienaar IS, Howell N, Elson JL. Mutpred mutational load analysis shows mildly deleterious mitochondrial DNA variants are not more prevalent in Alzheimer's patients, but may be under-represented in healthy older individuals. Mitochondrion. 2017;34:141–146. doi:https://doi.org/10.1016/j.mito.2017.1004.1002. Epub 2017 Apr 1017. doi: https://doi.org/10.1016/j.mito.2017.04.002
- Tomas C, Newton J. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review. Biochem Soc Trans. 2018;46:547–553. doi:5https://doi.org/10.1042/BST20170503. Epub 20172018 Apr 20170517.
- Booth NE, Myhill S, McLaren-Howard J. Mitochondrial dysfunction and the pathophysiology of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Int J Clin Exp Med. 2012;5:208–220. Epub 2012 Jun 2015.
- Myhill S, Booth NE, McLaren-Howard J. Targeting mitochondrial dysfunction in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) – a clinical audit. Int J Clin Exp Med. 2013;6:1–15. Epub 2012 Nov 2020.
- Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. 2009;2:1–16. Epub 2009 Jan 2015.
- Maianski NA, Geissler J, Srinivasula SM, et al. Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ. 2004;11:143–153. doi:1https://doi.org/10.1038/sj.cdd.4401320.
- Lawson N, Hsieh CH, March D, et al. Elevated energy production in chronic fatigue syndrome patients. J Nat Sci. 2016;2:10.
- Vermeulen RC, Kurk RM, Visser FC, et al. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. J Transl Med. 2010;8:93. Doi:https://doi.org/10.1186/1479-5876-1188-1193 doi: https://doi.org/10.1186/1479-5876-8-93
- Tomas C, Brown A, Strassheim V, et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS One. 2017;12:e0186802. eCollection 0182017. doi: https://doi.org/10.1371/journal.pone.0186802
- Smits B, van den Heuvel L, Knoop H, et al. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion. 2011;11:735–738. doi:7https://doi.org/10.1016/j.mito.2011.1005.1005. Epub 2011 Jun 1012. doi: https://doi.org/10.1016/j.mito.2011.05.005
- Williams YJ, Jantke RL, Jason LA. Chronic fatigue syndrome: case Definitions and diagnostic Assessment. N Y State Psychol. 2014;26:41–45.
- Blokhin A, Vyshkina T, Komoly S, et al. Variations in mitochondrial DNA copy numbers in MS brains. J Mol Neurosci. 2008;35:283–287. doi:2https://doi.org/10.1007/s12031-12008-19115-12031. Epub 12008 Jun 12020. doi: https://doi.org/10.1007/s12031-008-9115-1
- De Menezes ECS, Brown AE, Bowman SJ, et al. Mitochondrial DNA copy number is not associated with fatigue status in Primary Sjögren’s syndrome. Fatigue. 2018;6:123–131.
- Varhaug KN, Vedeler CA, Myhr KM, et al. Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis. Mitochondrion. 2017;34:32–35. doi:https://doi.org/10.1016/j.mito.2016.1012.1003. Epub 2016 Dec 1023. doi: https://doi.org/10.1016/j.mito.2016.12.003
- Lowes H, Pyle A, Duddy M, et al. Cell-free mitochondrial DNA in progressive multiple sclerosis. Mitochondrion. 2018;8:30101–30106.
- Lewis I, Pairman J, Spickett G, et al. Is chronic fatigue syndrome in older patients a different disease? – a clinical cohort study. Eur J Clin Invest. 2013;43:302–308. doi:3https://doi.org/10.1111/eci.12046. Epub 12013 Feb 12049.
- Collin SM, Crawley E, May MT, et al. The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database. BMC Health Serv Res. 2011;11:217), Doi:https://doi.org/10.1186/1472-6963-1111-1217 doi: https://doi.org/10.1186/1472-6963-11-217
- Grady JP, Campbell G, Ratnaike T, et al. Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain. 2014;137:323–334. doi:3https://doi.org/10.1093/brain/awt1321. Epub 2013 Nov 1025. doi: https://doi.org/10.1093/brain/awt321